지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
This study aims to assess the aggregate contribution of new drugs to the increase in life expectancy. We constructed a panel data combining mortality data in KOSIS and a drug dataset generated by assigning new drugs listed in 2000~2009 to their respective ICD codes. We found that 10% increase in stock of new drug led to 0.13~0.27% increase in the probability of survival to age 65. Due to lack of disease-specific life table, we used indirect approach to estimate the effect of new drugs on longevity. Using ordinary least squares, the estimate of the probability of survival to age 65 (logarithm) on life expectancy for all ages was 24.92. In conclusion, the increase in life expectancy of the entire population in Korea between 2000 and 2009 resulting from NMEs is 1.95 years, which explains 46.6% of real increase in life expectancy.
목차
등록된 정보가 없습니다.
참고문헌 (8)
참고문헌 신청
Cremieux Pierre-Yves / 2007 / Pharmaceutical Spending and Health Outcomes, In Pharmaceutical innovation : Incentives, Competition, and Cost-Benefit Analysis in International Perspective / Cambridge University Press
Lichtenberg R. Frank / 2005 / The impact of new drug launches on longevity : Evidence from longitudinal, disease-level data from 52 countries, 1982~2001 / International Journal of Health Care Finance and Economics 5:47
Hsieh Chee Ruey / 2007 / Pharmaceutical Innovation and Health outcomes : Empirical evidence from Taiwan, In Pharmaceutical innovation : Incentives, Competition, and Cost-Benefit Analysis in International Perspective / Cambridge University Press
권혜영 / 2011 / 신약도입에 따른 약품비 증가요인 분석 / 보건경제와 정책연구 17(2):151~169
보건복지부 / 2010 / 건강보험정책 관련 주요 참고자료
Lichtenberg R. Frank / 2005 / The impact of new drug launches on longevity : Evidence from longitudinal, disease-level data from 52 countries, 1982~2001 / International Journal of Health Care Finance and Economics 5:47
Hsieh Chee Ruey / 2007 / Pharmaceutical Innovation and Health outcomes : Empirical evidence from Taiwan, In Pharmaceutical innovation : Incentives, Competition, and Cost-Benefit Analysis in International Perspective / Cambridge University Press
권혜영 / 2011 / 신약도입에 따른 약품비 증가요인 분석 / 보건경제와 정책연구 17(2):151~169
보건복지부 / 2010 / 건강보험정책 관련 주요 참고자료
이 논문의 저자 정보
최근 본 자료
댓글(0)
0